Article | October 25, 2021

How To Build A Successful, Decentralized Clinical Trial And Avoid Common Mistakes

By Todd McGrath


The Rise of Decentralized Clinical Trials

Given the complexities of today’s clinical trial environment, coupled with advances in information technology, the demand for decentralized clinical trials (DCT) has been steadily increasing over the past seven years. Starting in 2020, the number of decentralized trials spiked significantly due, in large part, to the challenges of implementing trials during the COVID-19 pandemic. The pandemic led to many clinical trials being delayed or closed, putting the patients’ continuity of care and treatment at risk, and placing the success of the trial in jeopardy.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader

MRN - Medical Research Network